Grant receiving institution:
University Hospital Centre Osijek, J. Huttlera 4, 31 000 Osijek
Research and diagnostics of malignant, infectious and rare metabolic diseases based on MALDI TOF technology
European regional development fund
Operational Programme “Competitiveness and Cohesion 2014 – 2020”
Assist. Prof. Željko Debeljak, PhD, medical biochemistry specialst, EUSpLM, Clinical Chemistry Department leader
Assist. Prof. Željko Debeljak, PhD, medical biochemistry specialist, EUSpLM, Clinical Chemistry Department leader
Prof. Branko Dmitrović, MD, PhD, pathology specialist, manager of Clinical Institute of Pathology and Forensic Medicine
Assoc. Prof. Domagoj Drenjančević, MD, PhD, medical microbiology and parasitology specialist, Blood Donors’ Serology and Immunohematological Diagnostics Department leader
Assist. Prof. Sanja Mandić, PhD, medical biochemistry specialist, EUSpLM, Pharmacokinetics and Analitical Toxicology Department leader
Assist. Prof. Vatroslav Šerić, PhD, medical biochemistry specialist, EUSpLM, manager of Clinical Laboratory Diagnostics Insititute
Prof. Slavica Kvolik, MD, PhD, anesthesiology and reanimatology specialist, manager of Intensive Care Institute
Sanja Pešić, univ.spec. oec., deputy director for finances
Boris Flegar, dipl. oec., Procurement Department leader
All team members are emplyees of University Hospital Centre Osijek.
Nikolina Varda, mag. iur.
The aim of the project is to fulfill requirements of modern scientific research at University Hospital Centre Osijek by acquiring mass microscope and MALDI TOF/TOF mass spectrometer along with the supporting equipment and by associated laboratory interior design adjustments. It is expected that this step would enable realization of University Hospital Centre Osijek research potentials for development of the knowledge based healthcare system.
In order to conduct high quality research at University Hospital Centre Osijek and in order to advance the diagnostics of malignant diseases, breast cancer in particular, makes investment in this project so important. Moreover, this investment will enable better understanding of metastatic diseases’ development which, in turn, may lead to more efficient therapy for patients coming from Osijek and Osječko-baranjska county but also for patients coming from other parts of Croatia. Besides the malignant diseases, this equipment is expected to improve the diagnostics of rare metabolic diseases like lipid storage disorders as well as the diagnostics of sepsis and it may improve the time to treatment accompanied by reduced mortality. The equipment is expected to improve research and development of diagnostics of given diseases which, at the moment, is not efficient enough in terms of scientific personnel management and in terms of patient treatment, alike. Croatian Ministry of Health will provide the necessary support to University Hospital Centre Osijek for achievement of the expected goals.